AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
53.36
-1.68 (-3.05%)
At close: Jul 31, 2026, 4:00 PM EDT
54.00
+0.64 (1.20%)
After-hours: Jul 31, 2026, 7:34 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.58 billion as of July 31, 2026. Its market cap has increased by 115.28% in one year.
Market Cap
1.58B
Enterprise Value
1.57B
1-Year Change
115.28%
Ranking
Category
Stock Price
$53.36
ChartMarket Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.58B, an increase of 411.79%. That is a compound annual growth rate of 18.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.58B | 17.70% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 1.64B |
| Ascentage Pharma Group International | 1.61B |
| Sarepta Therapeutics | 1.61B |
| Septerna | 1.61B |
| Zymeworks | 1.59B |
| Recursion Pharmaceuticals | 1.59B |
| Maze Therapeutics | 1.57B |
| Innoviva | 1.56B |